Positives

• A double-blind randomized placebo-controlled trial of hydrolyzed chicken Type II collagen in patients with joint discomfort found significant alleviation of pain and improved joint function compared with placebo PMC.
  
  
• A 2025 trial combining UC-II with hydrolyzed Type I in knee osteoarthritis found combined therapy outperformed either type alone in pain and function endpoints Scientific Reports.
  
  

Negatives

• UC-II has not been tested in Long COVID specifically; the mechanism (oral tolerance to autoreactive T cells) is most relevant to autoimmune-flavored joint pain rather than general musculoskeletal complaints PMC.
  
  

Hurdles & Side Effects

• UC-II is dosed in milligrams (about 40 mg/day) versus 2.5-15 g/day for hydrolyzed collagen, and patients confusing the two often under- or over-dose; the two forms also act through different mechanisms (oral tolerance via GALT vs cartilage substrate) Examine.com.
• Cost is a real hurdle: NOW Foods UC-II 40 mg runs roughly $25-30 per month, and Schiff Move Free Ultra UC-II is similarly priced at major retailers like Costco, Walmart, CVS and Target.
• Patients on combined UC-II and hydrolyzed collagen for knee osteoarthritis at 12 weeks commonly see no benefit over placebo, so patients comparing the two should know efficacy data is mixed even at recommended doses Nature.
• Patients should look for the trademarked Lonza UC-II ingredient on the label rather than generic “type II collagen,” because not all undenatured type II collagen products are interchangeable Taylor & Francis.